Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

Por Emery, Paul, Tanaka, Yoshiya, Cardillo, Tracy, Schlichting, Douglas, Rooney, Terence, Beattie, Scott, Helt, Cameron, Smolen, Josef S.
Publicado no Arthritis Res Ther (2020)

Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis

Por Emery, Paul, Tanaka, Yoshiya, Cardillo, Tracy, Schlichting, Douglas, Rooney, Terence, Beattie, Scott, Helt, Cameron, Smolen, Josef S.
Publicado no Arthritis Res Ther (2020)

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)